Foley Forward: Brainwaves Event
Brainwaves ist Teil der Foley Forward-Veranstaltungsreihe und bietet ein intensives Erlebnis mit Einblicken in die Bereiche Gesundheitswesen, Biowissenschaften und Technologie.
An exclusive gathering of business and legal executives will discuss and explore fundamental shifts driving change and disruption in health technology. Our program will be grounded around three key concepts – Tech. People. Money.
Die Teilnehmer werden in die Welt der erweiterten Realität eintauchen, an Diskussionen in kleinen Gruppen teilnehmen, um neue Denkanstöße zu erhalten, und mit wichtigen Erkenntnissen von Experten der Branche nach Hause gehen.
Tagesordnung
Date and Time: Wednesday, May 10, 2023 | 1:00 p.m. – 7:30 p.m. ET
Venue: The Tower | 101 Arlington St., Boston, MA 02116
| 1:00 p.m. – 1:30 p.m. | GUEST ARRIVAL AND REGISTRATION |
| 1:30 p.m. – 1:35 p.m. | WELCOME |
| Library – 4th Floor | |
| Daljit Doogal, Chairman and CEO, Foley & Lardner | |
| 1:35 p.m. – 1:40 p.m. | OPENING REMARKS |
| Library – 4th Floor | |
| Pavan Agarwal, Partner, Foley & Lardner | |
| 1:40 p.m. – 2:40 p.m. | THE CHAOTIC FUTURE OF HEALTH CARE |
| Library – 4th Floor | |
| Nick Webb, Founder and CEO, LeaderLogic | |
| 2:40 p.m. – 3:40 p.m. | TECH, PEOPLE, MONEY: EXECUTIVE PERSPECTIVES |
| Library – 4th Floor | |
| Moderator: Susan Pravda, Partner, Foley & Lardner | |
| Beth Mosier, Director, West Monroe Partners | |
| Geeta Nayyar, M.D., MBA, Former Senior Vice President and Chief Medical Officer, Salesforce | |
| Derek Ritchea, Managing Director, Lincoln International | |
| Debanjan Saha, CEO, DataRobot | |
| Peter Slavin, M.D., Operating Partner, Advent International; Former President, Massachusetts General Hospital | |
| 3:40 p.m. – 4:00 p.m. | NETWORKING BREAK |
| 4:00 p.m. – 5:00 p.m. | BRAIN TRUSTS |
| Breakout 1 – Parlor (Main) – 2nd Floor Moderator: Stuart Blitz, Co-Founder and Chief Operating Officer, Hone Health |
|
| Breakout 2 – Parlor (Turret) – 2nd Floor Moderator: Ateev Mehrotra, M.D., M.P.H., Professor, Harvard Medical School |
|
| Breakout 3 – Green Room – 3rd Floor Moderator: Ryan Russell, Founder, Health Tech Nerds |
|
| Breakout 4 – Library – 4th Floor Moderator: Nick Webb, Founder and CEO, LeaderLogic |
|
| 5:15 p.m. – 5:30 p.m. | CLOSING INSIGHTS |
| Library – 4th Floor | |
|
Pavan Agarwal, Partner, Foley & Lardner Casey Knapp, Partner, Foley & Lardner |
|
| 5:30 p.m. – 7:30 p.m. | NETWORKING RECEPTION AND TECH DEMOS |
| Lounge 1887 – 1st Floor |
Vortragende
Stuart Blitz
Co-Founder and Chief Operating Officer
Hone Health
Ateev Mehrotra, M.D., M.P.H.
Professor
Harvard Medical School
Geeta Nayyar, M.D., M.B.A.
Former Senior Vice President and Chief Medical Officer
Salesforce
Derek Ritchea
Managing Director
Lincoln International
Ryan Russell
Founder
Health Tech Nerds
Debanjan Saha
CEO
DataRobot
Peter Slavin, M.D.
Operating Partner, Advent International; Former President Massachusetts General Hospital
Nick Webb
Founder and CEO
LeaderLogic
Cortina Health couples patent-pending AI technology with a national network of dermatologists and mail-order pharmacies to enable an online, personalized approach to skincare.
CranioSense is a clinical stage startup subsidiary of Vivonics on a mission to unlock the hidden parameters of brain health by enabling on demand neurological insight and treatment across the neurological care spectrum. To address medical needs following a traumatic brain injury, CranioSense developed IPASS, a non-invasive technology that measures intracranial pressure in seconds without the need to drill a hole in the skull or insert a sensor into the brain.
Operating at the intersection of blockchain and genomics, Genobank.io is the first company to enable users to establish end-to-end ownership and control over their personal genetic information. Through the use of Non-Fungible Tokens (NFTs), Genobank.io allows individuals to share (and revoke) access to health care providers, researchers, and companies.
Operating at the intersection of blockchain and genomics, Genobank.io is the first company to enable users to establish end-to-end ownership and control over their personal genetic information. Through the use of Non-Fungible Tokens (NFTs), Genobank.io allows individuals to share (and revoke) access to health care providers, researchers, and companies.
